Corporate/Financial News Personal care COVID-19 monkeypox Printing and Packaging Pharmaceuticals Government and Military Security and asset marking
APDN to Report Q1 FY’23 Financial Results; Investor Conference Call/Webcast 2/9
February 2, 2023
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
December 14, 2022
APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in NY
October 24, 2022
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30, 2022
APDN, Cornell University College of Veterinary Medicine Research Collaboration
September 8, 2022
APDN to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 7, 2022
Get Social